生物活性 | |||
---|---|---|---|
描述 | Chrysotoxine inhibits both Src and Akt. It decreases the characteristics of cancer stem cells (CSCs) by lowering Src/Akt signaling. Chrysotoxine decreases cell viability and boosts apoptosis in H460 and H23 cells, but not in non-tumor cell lines. It exhibits quick excretion and limited bioavailability in rats. Chrysotoxine is employed in cancer[1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.14mL 0.63mL 0.31mL |
15.71mL 3.14mL 1.57mL |
31.41mL 6.28mL 3.14mL |
参考文献 |
---|